{
    "eid": "2-s2.0-85061341248",
    "title": "The effect of direct hemoperfusion with polymyxin B immobilized cartridge on meropenem in critically ill patients requiring renal support",
    "cover-date": "2019-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Critical Care and Intensive Care Medicine",
            "@code": "2706",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Continuous venovenous hemofiltration",
        "Hemoperfusion",
        "Meropenem",
        "Polymyxin B immobilized cartridge"
    ],
    "authors": [
        "Wanchana Singhan",
        "Somratai Vadcharavivad",
        "Nutthada Areepium",
        "Supeecha Wittayalertpanya",
        "Weerachai Chaijamorn",
        "Nattachai Srisawat"
    ],
    "citedby-count": 6,
    "ref-count": 27,
    "ref-list": [
        "Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data",
        "Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012",
        "Acute kidney injury in critically ill patients with sepsis: clinical characteristics and outcomes",
        "Innate immune sensing and its roots: the story of endotoxin",
        "History and current status of polymyxin B-immobilized fiber column for treatment of severe sepsis and septic shock",
        "Effect of targeted polymyxin B hemoperfusion on 28-Day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial",
        "Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial",
        "Effects of polymyxin B hemoperfusion on mortality in patients with severe sepsis and septic shock: a systemic review, meta-analysis update, and disease severity subgroup meta-analysis",
        "Blood purification and mortality in sepsis: a meta-analysis of randomized trials",
        "Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis",
        "Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (Toraymyxin(R))",
        "Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (Toraymyxin(R)). Part 2: Adsorption of two drugs to Toraymyxin PMX-20R cartridges",
        "Meropenem: a review of its use in patients in intensive care",
        "The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients",
        "A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study",
        "Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration",
        "Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy",
        "Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration",
        "Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection",
        "Drug dosing in continuous renal replacement therapy: general rules",
        "Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis",
        "The pharmacokinetics of meropenem in volunteers",
        "Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration",
        "Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients",
        "Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration",
        "Pharmacokinetics of meropenem in critically ill patients with acute renal failure treated by continuous hemodiafiltration",
        "Pharmacokinetics of meropenem administered with prolonged infusion time in patients receiving continuous veno-venous hemofiltration"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022182",
            "affilname": "Siam University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022182",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University",
        "Toray Industries"
    ]
}